Media for culturing stem cells
View Patent ↗Well-defined, xeno-free culture media which comprise a TGF-beta isoform or the chimera formed between IL6 and the soluble IL6 receptor (IL6RIL6), which are capable of maintaining stem cells, and particularly, human embryonic stem cells, in an undifferentiated state are provided. Also provided are cell cultures comprising the culture media and the stem cells and methods of expanding and deriving embryonic stem cells in such well-defined, xeno-free culture media. In addition, the present invention provides methods of differentiating ESCs or EBs formed therefrom for the generation of lineage specific cells.
1. A culture medium comprising a TGFβ3 isoform and being serum-free, devoid of animal contaminant, feeder-free and protein carrier-free and capable of maintaining stem cells in an undifferentiated state.
2. A cell culture comprising the culture medium of claim 1 and said stem cells.
3. The culture medium claim 1 , wherein said stem cells are embryonic stem cells.
4. The culture medium of claim 1 , wherein said culture medium is capable of expanding said stem cells in an undifferentiated state.
5. The culture medium of claim 1 , wherein said TGFβ 3 is provided at a concentration of 2 ng/ml.
6. The culture medium of claim 1 , wherein said culture medium comprises basic fibroblast growth factor (bFGF).
7. The culture medium of claim 6 , wherein said bFGF is provided at a concentration of at least 4 ng/ml.
8. The culture medium of claim 3 , wherein said embryonic stem cells are human embryonic stem cells.
9. The cell culture of claim 2 being a suspension culture which is devoid of substrate adherence.
10. The culture medium of claim 1 , being capable of maintaining stem cells in an undifferentiated state for at least 53 passages.
11. The culture medium of claim 1 , wherein said TGFβ3 is provided at a concentration of at least 0.5 ng/ml.
12. The culture medium of claim 6 , wherein said bFGF is provided at a concentration of at least 2 ng/ml.
13. The culture medium of claim 6 , TGFβ3 is provided at a concentration of at least 0.5 ng/ml and wherein said bFGF is provided at a concentration of at least 2 ng/ml.
14. The culture medium of claim 6 , wherein said TGFβ3 is provided at a concentration of 2 ng/ml and wherein said bFGF is provided at a concentration of 10 ng/ml.